The Scientific Leadershp Council of the Pulmonary Hypertension Association

The scientific program of the Pulmonary Hypertension Association is guided by the association’s Scientific Leadership Council. The Council includes the following health care professionals:

• David B. Badesch, MD, SLC Chair, University of Colorado, Health Sciences Center, Denver, Colorado

• Robyn J. Barst, MD, SLC Immediate Past Chair, Columbia Presbyterian Medical Center Babies Hospital, New York, New York

• Vallerie V. McLaughlin, MD, SLC Vice-Chair, University of Michigan Health System, Ann Arbor, Michigan

• Raymond L. Benza, MD, University of Alabama, Birmingham, Alabama

• Todd Bull, MD, University of Colorado Health Sciences Center, Denver, Colorado

• Richard N. Channick, MD, UCSD Medical Center, San Diego, California

• C. Gregory Elliott, MD, LDS Hospital, University of Utah School of Medicine, Salt Lake City, Utah

• Karen A. Fagan, MD, Chair, Scientific Sessions Committee, University of Colorado Health Sciences Center, Denver, Colorado

• Adaani Frost, MD, Baylor College of Medicine, Houston, Texas

• Nazzareno Galiè, MD, Universita di Bologna, Bologna, Italy

• Nicholas S. Hill, MD, Division of Pulmonary, Critical Care and Sleep Medicine, Tufts-New England Medical Center, Boston, Massachusetts

• Marc Humbert, MD, Hopital Antoine Beclere, Clamart, France

• Dunbar Ivy, MD, University of Colorado, Denver, Colorado

• Anne M. Keogh, MD, St. Vincent’s Public Hospital, Sydney, Australia

• Michael J. Krowka, MD, Chair, Medical Sessions, Committee, Mayo Clinic, Rochester, Minnesota

• David Langleben, MD, Jewish General Hospital, Montreal, Quebec, Canada

• James E. Loyd, MD, Vanderbilt University Medical Center, Nashville, Tennessee

• Michael D. McGoon, MD, Chair, PHA Board of Trustees, Pulmonary Hypertension Clinic/Mayo Clinic, Rochester, Minnesota

• Srinivas Murali, MD, Chair, Education Committee, Allegheny General Hospital, Pittsburgh, PA

• John H. Newman, MD, Chair, Research Committee, Vanderbilt Medical School, Nashville, Tennessee

• Ronald J. Oudiz, MD, Liu Center for Pulmonary Hypertension, Los Angeles Biomedical Research Institute, Harbor-UCLA Medical Center, Torrance, California

• Marlene Rabinovitch, MD, Stanford University, School of Medicine Stanford, California

• Ivan M. Robbins, MD, Vanderbilt University, Nashville, Tennessee

• Julio Sandoval, MD, Cardiopulmonary Department, National Institute of Cardiology of Mexico, Tlalpan, Mexico

• James Seibold, MD, University of Michigan Health System, Ann Arbor, Michigan

• Victor F. Tapson, MD, Division of Pulmonary and Critical Care Medicine, Duke University Medical Center, Durham, North Carolina,

Liaisons

• Joy Beckmann, RN, MSN Chair, PH Resource Network, Torrance, California

• Joanne Sperando Schmidt, Patient Liaison

• Carol E. Vreim, PhD, Division of Lung Diseases, NHBLI, Bethesda, Maryland

Emeritus Members

• Bruce H. Brundage, MD St. Charles Medical Center-Bend, Bend, Oregon

• Alfred P. Fishman, MD, University of Pennsylvania Health System, Philadelphia, Pennsylvania

The Mission of the Scientific Leadership Council is to provide medical and scientific guidance and support to the PHA by:

• Developing and disseminating knowledge for diagnosing and treating pulmonary hypertension

• Advocating for patients with pulmonary hypertension

• Increasing involvement of basic and clinical researchers and practitioners

More information on PHA’s Scientific Leadership Council and associated committees can be found at: www.PHAssociation.org/SLC/